Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis
- PMID: 35697538
- PMCID: PMC9187865
- DOI: 10.1016/j.therap.2022.05.006
Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis
Keywords: Adverse drug reaction; COVID-19 vaccine; Cross-reactivity; Immune thrombocytopenia; Pharmacovigilance.
References
-
- Audia S., Mahévas M., Samson M., Godeau B., Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16:620–632. - PubMed
-
- Moore N., Berdaï D., Blin P., Droz C. Pharmacovigilance - The next chapter. Therapie. 2019;74:557–567. - PubMed
-
- Perricone C., Ceccarelli F., Nesher G., Borella E., Odeh Q., Conti F., et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res. 2014;60:226–235. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources